Charter Hall Group (CHC)
Australian Securities Exchange · Australia · prices in AUD · close of 19 Oct 2026
Key indicators
| Last close | AUD 19.35 |
|---|---|
| 52-week range | 17.49 – 25.41 |
| Return, 1 month / 3 months | +5.6% / −14.0% |
| Return, 1 year / 3 years | −13.6% / +134.0% |
| Trend | Below its 200-day average |
| RSI (14) | 58 |
| Volatility (1 year) | 30.1% |
| Worst drawdown (1 year) | -30.4% |
| Average daily value traded | 33.78M AUD |
| Dividend yield | 2.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Charter Hall Group is an Australian property investment and funds management business. It develops, owns and manages commercial, industrial, retail and social infrastructure properties, working with institutional and wholesale investors through a partnership model. Its customers include large investors and tenants who occupy the buildings it manages. The company is based in Australia and operates across the country's main property markets, drawing income from property investment and from managing funds on behalf of its partners.
On this site Charter Hall Group appears as a stock on the Australian Securities Exchange (Australia), code CHC, with prices in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Charter Hall Group (CHC) trades on the Australian Securities Exchange in Australia. It last closed at AUD 19.35 on 19 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 424 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 13.6% and over the last three months it fell 14.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 61 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -7.3% | ||
| From 52-week high | -23.6% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -14.0% | ||
| 6-month return | -2.6% | ||
| 12-month return, skipping the last month | -18.2% | ||
| Risk (lower is better) | 84 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility (1 year) | 30.1% | ||
| Worst drawdown (1 year) | -30.4% | ||
| Liquidity | 97 · Strong | Trades actively. | |
| Average daily value traded | 33.78M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.6% | ||
| Years with dividends | 6 |
Strengths
- Risk (lower is better): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +4.0% |
|---|---|
| 1 month | +5.6% |
| 3 months | −14.0% |
| 6 months | −2.6% |
| 1 year | −13.6% |
| 3 years | +134.0% |
| 5 years | +28.0% |
Signals
| 50-day / 200-day average | 19.39 / 20.88 |
|---|---|
| Golden / death cross (60 days) | Death, 24 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.59 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Jun 2026 | AUD 0.2584 |
| 30 Dec 2025 | AUD 0.2483 |
| 27 Jun 2025 | AUD 0.2438 |
| 30 Dec 2024 | AUD 0.2342 |
| 27 Jun 2024 | AUD 0.2300 |
| 28 Dec 2023 | AUD 0.2209 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.